Phase I Study of Oral ONC206 in Recurrent and Rare Primary Central Nervous System Neoplasms

NCT04541082 · clinicaltrials.gov ↗
PHASE1
Phase
RECRUITING
Status
102
Enrollment
INDUSTRY
Sponsor class

Conditions

Interventions

Sponsor

Jazz Pharmaceuticals

Collaborators